News
In this interview, Siddiqui discusses how Seer’s Proteograph™ Product Suite is expanding ... One key challenge is the vast dynamic range of protein concentrations in plasma, which can obscure the ...
Welcome to Seer first quarter 2025 earnings conference call. At this time all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session.
In this webinar, you’ll hear how one of the largest multiomics observational studies to date has revealed lung cancer biomarkers from the blood plasma proteome. Our expert speakers will discuss how ...
The abstract, titled "Clinical and biological implications of plasma proteomic patterns in ... us closer to realizing the full potential of proteomics in oncology." ...
We started Seer with the vision to change the arc of proteomics by providing unprecedented ... which extended the power of Proteograph XT beyond plasma and tissue analysis. We've been very pleased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results